Synergism of KRAS G12C Inhibitor and mTOR Inhibitor in Lung Adenocarcinoma and Squamous Cell Carcinoma

被引：0
|
作者：
Ito, M. [1 ,2 ]
Miyata, Y. [2 ]
Hirano, S. [2 ]
Morihara, N. [2 ]
Irisuna, F. [2 ]
Takemoto, M. [2 ]
Tsutani, Y. [1 ]
Okada, M. [2 ]
机构：
[1] Kindai Univ, Osaka, Japan
[2] Hiroshima Univ, Hiroshima, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
KRAS; mTOR; squamous cell carcinoma;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP02.01-09
引用
收藏
页码：S429 / S429
页数：1
相关论文
共 50 条
  • [21] Glecirasib (KRAS G12C inhibitor) in combination with JAB-3312 (SHP2 inhibitor) in patients with KRAS p.G12C mutated solid tumors
    Wang, J.
    Zhao, J.
    Zhong, J.
    Li, X.
    Fang, J.
    Yu, Y.
    Li, X.
    Fang, X.
    Chang, J.
    Liu, Z.
    Zhao, Y.
    Song, Q.
    Bai, C.
    Wang-Gillam, A.
    Ding, Y.
    Rao, Z.
    Bi, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S459 - S459
  • [22] KRAS G12C mutations in non-small cell lung cancer
    Li, J. J.
    Wu, X. J.
    Farzin, M.
    Bray, V.
    Williamson, J.
    Pal, A.
    Yip, P. Y.
    Hagelamin, A.
    Ding, P.
    Nindra, U.
    Vinod, S.
    French, B.
    Chua, W.
    Gupta, R.
    Cooper, W. A.
    Wang, B.
    Lee, C. S.
    HISTOPATHOLOGY, 2024, 85 : 25 - 25
  • [23] Oncogenic non-G12C KRAS mutations in KRAS G12C mutated lung adenocarcinomas in TRACERx and GENIE: A reservoir for intrinsic resistance to KRAS G12C inhibitors
    Marinelli, D.
    Pisegna, S.
    Giammaruco, M.
    Chesi, P.
    Mammone, G.
    Ceddia, S.
    Gazzaniga, P.
    Cortesi, E.
    Gelibter, A. J.
    ANNALS OF ONCOLOGY, 2021, 32 : S1345 - S1346
  • [24] KO-2806, a next-generation farnesyl transferase inhibitor, re-sensitizes KRAS G12C NSCLC tumors to KRAS G12C mutant-specific inhibitors through mTOR signaling inhibition
    Patel, H.
    Chan, S.
    Smith, A.
    Burrows, F.
    Malik, S.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S146 - S146
  • [25] Multiple initiatives to conquer KRAS G12C inhibitor resistance from the perspective of clinical therapy
    Zhang, Junmin
    Zhang, Juanhong
    Leung, Elaine Lai-Han
    Yao, Xiao-Jun
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (02) : 101 - 106
  • [26] The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
    Canon, Jude
    Rex, Karen
    Saiki, Anne Y.
    Mohr, Christopher
    Cooke, Keegan
    Bagal, Dhanashri
    Gaida, Kevin
    Holt, Tyler
    Knutson, Charles G.
    Koppada, Neelima
    Lanman, Brian A.
    Werner, Jonathan
    Rapaport, Aaron S.
    San Miguel, Tisha
    Ortiz, Roberto
    Osgood, Tao
    Sun, Ji-Rong
    Zhu, Xiaochun
    McCarter, John D.
    Volak, Laurie P.
    Houk, Brett E.
    Fakih, Marwan G.
    O'Neil, Bert H.
    Price, Timothy J.
    Falchook, Gerald S.
    Desai, Jayesh
    Kuo, James
    Govindan, Ramaswamy
    Hong, David S.
    Ouyang, Wenjun
    Henary, Haby
    Arvedson, Tara
    Cee, Victor J.
    Lipford, J. Russell
    NATURE, 2019, 575 (7781) : 217 - +
  • [27] Prognostic value of KRAS G12C mutation in lung adenocarcinoma stratified by stages and radiological features
    Cao, Hang
    Ma, Zelin
    Li, Yuan
    Zhang, Yang
    Chen, Haiquan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023, 166 (06): : E479 - E499
  • [28] KRAS G12C lung adenocarcinoma represents a distinct group of patients with different response to immunotherapy
    Masfarre, L.
    Rocha, P.
    Clave, S.
    Moliner, L.
    Navarro-Gorro, N.
    Rios-Hoyo, A.
    Sanchez, I.
    Giner, M.
    Corbera, A.
    Taus, A.
    Bellosillo, B.
    Arriola, E.
    ANNALS OF ONCOLOGY, 2022, 33 : S109 - S109
  • [29] Overcoming KRAS G12C inhibitor resistance with a chaperone-mediated protein degrader (CHAMP)
    Endrino, Ines Pulido
    Luan, Qiyue
    Graeber, Jennifer
    Borger, Brianna
    Ying, Chenghao
    Li, Jinhua
    Yang, Zimo
    Wang, Zhiyong
    Wang, Yaya
    Sun, Yuetong
    Dai, Yan
    Papautsky, Ian
    Prince, Thomas L.
    Wang, Guoqiang
    Foley, Kevin P.
    Ying, Weiwen
    Shimamura, Takeshi
    CANCER RESEARCH, 2023, 83 (08)
  • [30] Overcoming KRAS G12C inhibitor resistance with chaperone-mediated protein degrader in NSCLC
    Pulido, Ines
    Graeber, Jennifer M.
    Borger, Brianna C.
    Foley, Kevin P.
    Ying, Weiwen
    Ying, Chenghao
    Li, Jinhua
    Wang, Yaya
    Sun, Yuetong
    Dai, Yan
    Wang, Guoqiang
    Prince, Thomas L.
    Shimamura, Takeshi
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
12345